Journal of Mid-life Health

: 2021  |  Volume : 12  |  Issue : 1  |  Page : 3--7

Polycystic ovarian syndrome and menopause in forty plus women

Sudhaa Sharma, Neha Mahajan 
 Department of Obstetrics and Gynecology, Government Medical College, SMGS Hospital, Jammu, Jammu and Kashmir, India

Correspondence Address:
Neha Mahajan
Assistant Professor, Department of Obstetrics and Gynaecology, SMGS Hospital Jammu - 180 001, Jammu and Kashmir

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age group, but it affects women's health and quality of life across the life course. During different stages of life, the PCOS phenotype can change, which requires a personalized diagnostic approach and treatment. With increasing age, the syndrome evolves from a reproductive disease to a more metabolic disorder. Along with various metabolic disturbances like insulin resistance and abnormalities of energy expenditure, PCOS is recognized as a major risk factor for the development of type 2 diabetes and cardiovascular disease (CVD) in later life. The aim of the current review was to conduct a nonsystematic review of published literature and research that has been presented so far regarding menopausal women with PCOS as well as the associated changes in hormone profile, their lipid profile, and various metabolic changes that occur. The current review may also contribute to raise awareness about the risk of hypertension and CVDs in postmenopausal women with PCOS.

How to cite this article:
Sharma S, Mahajan N. Polycystic ovarian syndrome and menopause in forty plus women.J Mid-life Health 2021;12:3-7

How to cite this URL:
Sharma S, Mahajan N. Polycystic ovarian syndrome and menopause in forty plus women. J Mid-life Health [serial online] 2021 [cited 2022 Oct 4 ];12:3-7
Available from:;year=2021;volume=12;issue=1;spage=3;epage=7;aulast=Sharma;type=0